Clinical Trials Logo

Citation(s)

Efficacy and Safety of Mesobotox as a Potential New Therapeutic Modality of Psoriasis Vulgaris in Comparison/Combination With Topical Calcineurin Inhibitor

Details for clinical trial NCT06203470